Quantitative Detection of the M204V Hepatitis B Virus Minor Variants by Amplification Refractory Mutation System Real-Time PCR Combined with Molecular Beacon Technology
暂无分享,去创建一个
G. Magiorkinis | E. Magiorkinis | A. Hatzakis | D. Paraskevis | V. Sypsa | G. Papatheodoridis | S. Manolakopoulos | E. Manesis | A. Beloukas | C. Haida | F. Ntziora | S. Chryssoy
[1] G. Dusheiko,et al. Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. , 2008, The Lancet. Infectious diseases.
[2] A. Lok,et al. Sensitive Line Probe Assay That Simultaneously Detects Mutations Conveying Resistance to Lamivudine and Adefovir , 2006, Journal of Clinical Microbiology.
[3] S. Hober,et al. Pyrosequencing: history, biochemistry and future. , 2006, Clinica chimica acta; international journal of clinical chemistry.
[4] George Kitis,et al. Outcome of hepatitis B e antigen–negative chronic hepatitis B on long‐term nucleos(t)ide analog therapy starting with lamivudine , 2005, Hepatology.
[5] E. Keeffe,et al. Management of Antiviral Resistance in Patients with Chronic Hepatitis B , 2004, Antiviral therapy.
[6] Sudhir Kumar,et al. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment , 2004, Briefings Bioinform..
[7] P. Cane,et al. Quantitation of hepatitis B lamivudine resistant mutants by real-time amplification refractory mutation system PCR. , 2004, Journal of hepatology.
[8] C. Osiowy,et al. Evaluation of the INNO-LiPA HBV Genotyping Assay for Determination of Hepatitis B Virus Genotype , 2003, Journal of Clinical Microbiology.
[9] Ching-Lung Lai,et al. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. , 2003, Gastroenterology.
[10] Michael D. Miller,et al. The Hepatitis B Virus Polymerase Mutation rtV173L Is Selected during Lamivudine Therapy and Enhances Viral Replication In Vitro , 2003, Journal of Virology.
[11] Yan Wang,et al. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization. , 2003, World journal of gastroenterology.
[12] Angeline Bartholomeusz,et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. , 2003, Gastroenterology.
[13] A. Lok,et al. Rapid and Sensitive Assays for Determination of Hepatitis B Virus (HBV) Genotypes and Detection of HBV Precore and Core Promoter Variants , 2003, Journal of Clinical Microbiology.
[14] H. Margolis,et al. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection , 2002, Journal of medical virology.
[15] Fabien Zoulim,et al. Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay , 2002, Journal of Clinical Microbiology.
[16] T. Okanoue,et al. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. , 2002, Journal of hepatology.
[17] R. D. de Man,et al. The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisation. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] Jun Fan,et al. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine. , 2002, Hepatobiliary & Pancreatic Diseases International.
[19] J.-H. Wang,et al. Fatal Hepatic Failure After Emergence of the Hepatitis B Virus Mutant During Lamivudine Therapy in a Patient with Liver Cirrhosis , 2002, Scandinavian journal of gastroenterology.
[20] G. Papatheodoridis,et al. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance , 2002, American Journal of Gastroenterology.
[21] J. Chi,et al. Fatal submassive hepatic necrosis associated with tyrosine-methionine-aspartate-aspartate-motif mutation of hepatitis B virus after long-term lamivudine therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] E. Puchhammer-Stöckl,et al. Comparison of Sequence Analysis and the INNO-LiPA HBV DR Line Probe Assay for Detection of Lamivudine-Resistant Hepatitis B Virus Strains in Patients under Various Clinical Conditions , 2001, Journal of Clinical Microbiology.
[23] D. Richman,et al. Nomenclature for antiviral‐resistant human hepatitis B virus mutations in the polymerase region , 2001, Hepatology.
[24] Y. Liaw. Impact of YMDD mutations during lamivudine therapy in patients with chronic hepatitis B. , 2001, Antiviral chemistry & chemotherapy.
[25] F. Baldanti,et al. Two Sensitive PCR-Based Methods for Detection of Hepatitis B Virus Variants Associated with Reduced Susceptibility to Lamivudine , 1999, Journal of Clinical Microbiology.
[26] C. Chu,et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy , 1999, Hepatology.
[27] Y. Shiratori,et al. YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection , 1999, Hepatology.
[28] A M Gewirtz,et al. Real time detection of DNA.RNA hybridization in living cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] K. Walters,et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine , 1998 .
[30] Amalio Telenti,et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis , 1998, Nature Biotechnology.
[31] K. Reddy,et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation , 1997, The Lancet.
[32] Sanjay Tyagi. Taking DNA probes into a protein world , 1996, Nature Biotechnology.
[33] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[34] C Summers,et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.